MMJ BioScience Files Pre Investigational New Drug (IND) Application With FDA For Pharmaceutical Cannabidiol (CBD …

News Image

MMJ BioScience’s FDA application to initiate clinical trials assessing the company’s cannabinoid pharmaceutical compounds for treating and/or preventing symptoms associated with multiple sclerosis (MS) has been filed

... read more at: http://www.prweb.com/releases/2017/12/prweb15000381.htm

by